T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
53 hedge funds and large institutions have $24.5M invested in T2 Biosystems, Inc in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
68% more call options, than puts
Call options by funds: $611K | Put options by funds: $363K
29% more capital invested
Capital invested by funds: $19M → $24.5M (+$5.56M)
15% more funds holding
Funds holding: 46 → 53 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$897K |
| 2 |
BlackRock
New York
|
+$838K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$838K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$408K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$393K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$274K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$185K |
| 3 |
AIP
ARS Investment Partners
New York
|
-$133K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$126K |
| 5 |
GS
Gagnon Securities
New York
|
-$66.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWM
51
Geneos Wealth Management
Englewood,
Colorado
| $5K | +$7.41K | +1 | New |
|
|
BG
52
Bollard Group
Boston,
Massachusetts
| $4K | -$7.41K | -1 | -50% |
|
|
KFS
53
Kelly Financial Services
Braintree,
Massachusetts
| $2.17K | – | – | – |
|
|
EIP
54
Ellis Investment Partners
Berwyn,
Pennsylvania
| $2K | – | – | – |
|
|
FHA
55
Flagship Harbor Advisors
Boston,
Massachusetts
| $1K | – | – | – |
|
|
SFA
56
Semmax Financial Advisors
Winston Salem,
North Carolina
| $1K | – | – | – |
|
57
Millennium Management
New York
| $276 | +$193K | +26 | +173% |
|
58
BNP Paribas Financial Markets
Paris,
France
| $3 | – | – | – |
|
|
AIP
59
ARS Investment Partners
New York
| – | -$133K | -21 | Closed |
|
60
Jane Street
New York
| – | -$59K | -9 | Closed |
|
|
TRCT
61
Tower Research Capital (TRC)
New York
| – | -$48K | -8 | Closed |
|
|
GCP
62
GSA Capital Partners
London,
United Kingdom
| – | -$33K | -5 | Closed |
|
|
CHP
63
Cable Hill Partners
Portland,
Oregon
| – | -$19K | -3 | Closed |
|
|
PAG
64
Private Advisor Group
Morristown,
New Jersey
| – | -$6K | -1 | Closed |
|
65
Simplex Trading
Chicago,
Illinois
| – | -$7.41K | -1 | Closed |
|
TTOO Hedge Fund Activity: Q3 2020 in Review
53 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2020, worth a combined $24.5M — up 29% from $19M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TTOO positions and 7 closed out — a net gain of 7 holders — while 17 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $897K. The largest seller was Susquehanna International Group, cutting an estimated $274K.
- 53 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2020, up from 46 in Q2 2020.
- Funds reported $24.5M of T2 Biosystems, Inc stock for Q3 2020, up 29% quarter-over-quarter.
- 14 funds opened new T2 Biosystems, Inc positions in Q3 2020 and 7 closed out, a net change of +7 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2020 was Vanguard Group, an estimated $897K added.
- The largest T2 Biosystems, Inc seller in Q3 2020 was Susquehanna International Group, an estimated $274K sold.
Based on aggregated 13F filings for Q3 2020.